Thanks, Matthias.

Here is another "demo" page that was started off the BioRDF page:
        http://esw.w3.org/topic/HCLSIG_BioRDF_Subgroup/Demo_Thoughts

It is solely focused on the AD Use Case.

Then there is the PD Use Case:
        http://esw.w3.org/topic/ParkinsonsDisease
        http://esw.w3.org/topic/HCLS/ParkinsonUseCase

and the more recent effort to seek synergies between the AD & PD Use Cases (synergies in SemWebTech techniques & tools, as well as scientific questions/objectives)
        http://esw.w3.org/topic/HCLS/IntegratedUseCase

Which brings up another issue. I thought we were converging on the idea the demos would driven by and built off the current AD and/or PD Use Cases? This is not to say we would want to include most if not all of the issues discussed on the page you've created. It only means we'd seek to put them in the context of the PD and/or AD Use Case.

This also brings up the issue of some of the other valuable Use Cases that have been discussed - e.g.:
        ACPP:
                http://esw.w3.org/topic/HCLS/ACPPTaskForce
        SPE:
                http://esw.w3.org/topic/HCLS/ScientificPublishingTaskForce
        BioONT:
http://esw.w3.org/topic/HCLS/OntologyTaskForce/POMR (see Motivating Use Cases)
                http://esw.w3.org/topic/HCLS/POMROntology
        DSE:
http://esw.w3.org/topic/HCLSIG/Drug_Safety_and_Efficacy (see Use Case context)

There is the other issue of demos worked on collectively by the HCLSIG and those that will be presented as a part of the special HCLSIG session at the Banff meeting worked on outside the direct auspices of this group collectively.

Finally, it's not clear to me how the tasks listed on various Task Force pages feed into the Use Cases, what their status is re: this issue (Use Case support), and whether they will be directly relevant to the HCLSIG group demo(s) - e.g.,
        BioRDF:
                http://esw.w3.org/topic/HCLSIG_BioRDF_Subgroup/Tasks
http://esw.w3.org/topic/BioRDF_Top_Level_Task (tasks down at the bottom) http://esw.w3.org/topic/HCLSIG_BioRDF_Subgroup/Tasks/ Using_SW_Technologies_to_Find_Small_Molecules_that_Bind_to_Proteins
        BioONT:
                http://esw.w3.org/topic/HCLS/OntologyTaskForce (see Work 
Products)
http://esw.w3.org/topic/HCLS/OntologyTaskForce/ Create_Bridging_Ontology_between_NeuronDB_and_CoCoDat_databases_and_UMLS _Common_Vocabulary (SenseLab, Cocodat, & UMLS bridge) http://esw.w3.org/topic/HCLS/OntologyTaskForce/DesignIssues (bench- to-bedside ontology) http://esw.w3.org/topic/HCLS/OntologyTaskForce/SeedOntology (seed ontology for bench-to-bedside) http://esw.w3.org/topic/HCLS/OntologyTaskForce/SeedOntology/ SeedOntologyDetailedFollowup (PATO expression of assertions about PD) - also a Chemical Ontology from NIST that I can't find the HCLSIG Wiki page for now
        SPE:
http://esw.w3.org/topic/HCLS/ScientificPublishingTaskForce (particularly the SPE Spec)
        ACPP:
                http://esw.w3.org/topic/HCLS/ACPPTaskForce/ACPPOntology
        DSE:
http://esw.w3.org/topic/HCLSIG/Drug_Safety_and_Efficacy (Task Objectives)

Cheers,
Bill

On Jan 18, 2007, at 7:30 AM, Matthias Samwald wrote:



Several proposals for Semantic Web demos have been made up to now, and it starts to get confusing. We need to collect all of these proposals in a single document in order to compare their advantages and disadvantages, and to find possible interconnections. I have created a wiki page where we can collect theses proposals:

http://esw.w3.org/topic/HCLSIG_Demo_Proposals

Please note that if we still want to present a HCLSIG demo at the ISMB conference, we should be aware that the deadline for paper submission is nearing (early February).

kind regards,
Matthias Samwald




Bill Bug
Senior Research Analyst/Ontological Engineer

Laboratory for Bioimaging  & Anatomical Informatics
www.neuroterrain.org
Department of Neurobiology & Anatomy
Drexel University College of Medicine
2900 Queen Lane
Philadelphia, PA    19129
215 991 8430 (ph)
610 457 0443 (mobile)
215 843 9367 (fax)


Please Note: I now have a new email - [EMAIL PROTECTED]




Reply via email to